The American Society for Radiation Oncology has developed a white paper on the safe use of integrating intensity-modulated radiation therapy (IMRT) into the radiation oncology clinic.
The American Society for Radiation Oncology has developed a white paper on the safe use of integrating intensity-modulated radiation therapy (IMRT) into the radiation oncology clinic.
The executive summary of this white paper was published in Practical Radiation Oncology, ASTRO’s clinical practice journal (2011; 1:190-5).
The white paper raises these main concerns:
"Intensity-modulated radiation therapy has been a tremendous advance in the way we treat patients by improving the planning and delivery of radiation therapy," said lead author Jean M. Moran, PhD, of the University of Michigan Medical Center in Ann Arbor. "IMRT is, however, incredibly time and resource intensive. It involves the use of sophisticated software and delivery systems and many hand-offs between team members throughout the simulation, planning, and delivery process. It is our hope that practitioners will use the tools and techniques presented in this document to reassess and strengthen their own IMRT programs."
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.